A 14-day course of the oral anti-inflammatory drug montelukast didn't shorten symptom duration in nonhospitalized US adults ...

A NEW clinical trial has found that the asthma drug montelukast does not shorten the duration of symptoms for ...

New research suggests that using the diabetes drug metformin for COVID-19 could help lower the risk of long Covid symptoms ...

About The Study: In this randomized clinical trial of outpatients with mild to moderate COVID-19, treatment with montelukast did not reduce duration of COVID-19 symptoms. These findings do not ...

It is not known if montelukast passes into breast milk. you have or have had any medical conditions. your child has a condition called phenylketonuria. The 5 mg and 4 mg chewable tablets contain ...

Patients sued, alleging montelukast can cause neuropsychiatric events and homicidal thoughts, as the drug crosses the blood-brain barrier. The Singulair label warns users that this can happen, and ...

DelveInsight’s Refractory Multiple Myeloma pipeline report depicts a robust space with 75+ active players working to develop ...

When it was prescribed within a week of SARS CoV-2 infection, metformin was associated with a 53% reduction in long COVID or death.

The Central Drug Regulatory Authority flagged four drugs as spurious and identified 49 others as not meeting quality ...

True or False: The CDC recommended that all adults receive a second dose of the 2024-2025 COVID vaccine 6 months after their ...

In line with the 'Not of Standard Quality' data provided by states, the Central Drug Standard Control Organisation (CDSCO), ...